Open Access
Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial
David Wang, Li Gui, Yi Dong, Hao Li, Shujuan Li, Huaguang Zheng, Anxin Wang, Xia Meng, Li-Ping Liu, Yi-Long Wang, Guangyao Wang, Jing Jing, Zixiao Li, Xing-Quan Zhao, Yong-Jun Wang
DOI: 10.1136/svn-2016-000008 Published 24 June 2016
David Wang
1Illinois Neurological Institute Stroke Network, Sisters of the Third Order of St. Francis Healthcare System, University of Illinois College of Medicine, Peoria, Illinois, USA
Li Gui
2Southwest Hospital Stroke Center, Third Military University of Medical Sciences, Chongqing, China
Yi Dong
3Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China
Hao Li
4China National Clinical Research Center for Neurological Diseases, Beijing, China
Shujuan Li
5Chaoyang Hospital Neurology Department, Capital Medical University, Beijing, China
Huaguang Zheng
6Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China
Anxin Wang
4China National Clinical Research Center for Neurological Diseases, Beijing, China
6Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China
Xia Meng
4China National Clinical Research Center for Neurological Diseases, Beijing, China
6Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China
Li-Ping Liu
6Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China
7Neurological Intensive Care Unit, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Yi-Long Wang
4China National Clinical Research Center for Neurological Diseases, Beijing, China
6Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China
Guangyao Wang
4China National Clinical Research Center for Neurological Diseases, Beijing, China
6Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China
Jing Jing
6Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China
7Neurological Intensive Care Unit, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Zixiao Li
4China National Clinical Research Center for Neurological Diseases, Beijing, China
6Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China
Xing-Quan Zhao
4China National Clinical Research Center for Neurological Diseases, Beijing, China
6Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China
Yong-Jun Wang
4China National Clinical Research Center for Neurological Diseases, Beijing, China
6Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China
8Department of Neurology, Beijing Tiantan Hospital, Vascular Neurology, Capital Medical University, Beijing, China

Submit a Response to This Article
No eLetters have been published for this article.
Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial
David Wang, Li Gui, Yi Dong, Hao Li, Shujuan Li, Huaguang Zheng, Anxin Wang, Xia Meng, Li-Ping Liu, Yi-Long Wang, Guangyao Wang, Jing Jing, Zixiao Li, Xing-Quan Zhao, Yong-Jun Wang
Stroke and Vascular Neurology Jun 2016, 1 (2) 29-36; DOI: 10.1136/svn-2016-000008

Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial
David Wang, Li Gui, Yi Dong, Hao Li, Shujuan Li, Huaguang Zheng, Anxin Wang, Xia Meng, Li-Ping Liu, Yi-Long Wang, Guangyao Wang, Jing Jing, Zixiao Li, Xing-Quan Zhao, Yong-Jun Wang
Stroke and Vascular Neurology Jun 2016, 1 (2) 29-36; DOI: 10.1136/svn-2016-000008
Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial
David Wang, Li Gui, Yi Dong, Hao Li, Shujuan Li, Huaguang Zheng, Anxin Wang, Xia Meng, Li-Ping Liu, Yi-Long Wang, Guangyao Wang, Jing Jing, Zixiao Li, Xing-Quan Zhao, Yong-Jun Wang
Stroke and Vascular Neurology Jun 2016, 1 (2) 29-36; DOI: 10.1136/svn-2016-000008